Comparison of the Oral (PABA) Pancreatic Function Test, the Secretin-pancreozymin Test and Endoscopic Retrograde Pancreatography in Chronic Alcohol Induced Pancreatitis

Overview

Journal Gut

Specialty Gastroenterology

Date 1985 Nov 1

PMID 3877666

Citations 6

Authors

A S Mee

A H Girdwood

E Walker

N H Gilinsky

R E KOTTLER

I N Marks

Affiliations

Soon will be listed here.

Abstract

The oral (PABA) pancreatic function test (PFT), the secretin-pancreozymin test and endoscopic retrograde pancreatography (ERCP) have been carried out in 32 patients with suspected chronic alcohol induced pancreatitis (CAIP) in order to evaluate which, if any, test was most likely to confirm the provisional diagnosis. Thirty one patients had changes of minimal (n = 6) moderate (n = 7) or advanced (n = 18) chronic pancreatitis on pancreatography, whilst one patient had a pancreas divisum. Eight hour urinary PABA excretion was significantly reduced in patients with moderate and advanced structural changes (p less than 0.001) and correlated significantly with all parameters of the PFT, although eight patients with an abnormal pancreatogram and pancreatic function test had a normal PABA value. The PFT was abnormal in 23 patients, but normal in five patients with an abnormal pancreatogram and low PABA value. Most patients with minimal change pancreatitis had a normal PABA test and PFT. We conclude that pancreatography appears to be the most sensitive method for detecting chronic pancreatic damage and for confirming a clinical diagnosis of chronic alcohol induced pancreatitis. Both the PFT and PABA test are useful confirmatory tests and whilst the PFT is slightly more sensitive for assessing pancreatic exocrine function, the PABA test is well tolerated and simple to perform. It may therefore be the complementary investigation of choice for this group of patients.

Citing Articles

Pancreatic endosonographic findings and clinical correlation in Crohn's disease.

Malluta E, Maluf-Filho F, Leite A, Ortiz-Agostinho C, Nishitokukado I, Andrade A Clinics (Sao Paulo). 2019; 74:e853.

PMID: 31166473 PMC: 6542499. DOI: 10.6061/clinics/2019/e853.

Exocrine pancreatic insufficiency: prevalence, diagnosis, and management.

Capurso G, Traini M, Piciucchi M, Signoretti M, Arcidiacono P Clin Exp Gastroenterol. 2019; 12:129-139.

PMID: 30962702 PMC: 6432881. DOI: 10.2147/CEG.S168266.

Diagnosing early-stage chronic pancreatitis: is endoscopic ultrasound a reliable modality?.

Catalano M J Gastroenterol. 2007; 42 Suppl 17:78-84.

PMID: 17238033 DOI: 10.1007/s00535-006-1915-x.

Assessment of gastrointestinal function and response to megesterol acetate in subjects with gastrointestinal cancers and weight loss.

Deutsch J, Kolhouse J Support Care Cancer. 2004; 12(7):503-10.

PMID: 15064933 DOI: 10.1007/s00520-004-0615-4.

Comparison of pancreatic morphology and exocrine functional impairment in patients with chronic pancreatitis.

Bozkurt T, Braun U, Leferink S, GILLY G, Lux G Gut. 1994; 35(8):1132-6.

PMID: 7523260 PMC: 1375069. DOI: 10.1136/gut.35.8.1132.

References

Kasugai T, Kuno N, Kizu M, Kobayashi S, Hattori K . Endoscopic pancreatocholangiography. II. The pathological endoscopic pancreatocholangiogram. Gastroenterology. 1972; 63(2):227-34. View

Nardi G . Serum "trypsin" (or arginine exopeptidase) screening test for cancer of the panceas. Gastroenterology. 1960; 38:50-1. View

Nakano S, Horigauchi Y, Takeda T, Suzuki T, Nakajima S . Comparative diagnostic value of endoscopic pancreatography and pancreatic function tests. Scand J Gastroenterol. 1974; 9(4):383-90. View

Bornschein W, Goldmann F, Otte M . [Methodological and first clinical investigations using a new pancreatic function test]. Clin Chim Acta. 1976; 67(1):21-7. DOI: 10.1016/0009-8981(76)90212-6. View

Gyr K, Stalder G, Schiffmann I, Fehr C, Vonderschmitt D, FAHRLAENDER H . Oral administration of a chymotrypsin-labile peptide--a new test of exocrine pancreatic function in man (PFT). Gut. 1976; 17(1):27-32. PMC: 1411054. DOI: 10.1136/gut.17.1.27. View

Cotton P . ERCP. Gut. 1977; 18(4):316-41. PMC: 1411454. DOI: 10.1136/gut.18.4.316. View

Arvanitakis C, Greenberger N . Diagnosis of pancreatic disease by a synthetic peptide. A new test of exocrine pancreatic function. Lancet. 1976; 1(7961):663-6. DOI: 10.1016/s0140-6736(76)92777-x. View

Arvanitakis C, Cooke A . Diagnostic tests of exocrine pancreatic function and disease. Gastroenterology. 1978; 74(5 Pt 1):932-48. View

Nousia-Arvanitakis S, Arvanitakis C, Desai N, Greenberger N . Diagnosis of exocrine pancreatic insufficiency in cystic fibrosis by the synthetic peptide N-benzoyl-L-tyrosyl-p-aminobenzoic acid. J Pediatr. 1978; 92(5):734-7. DOI: 10.1016/s0022-3476(78)80139-5. View

10.

Imamura K, Nakamura T, Miyazawa T, Abe Y, Kobayashi M, Takebe K . Oral administration of chymotrypsin labile peptide for a new test of exocrine pancreatic function (PET) in comparison and pancreozymin-secretin test. Am J Gastroenterol. 1978; 69(5):572-8. View

11.

Sacher M, Kobsa A, SHMERLING D . PABA screening test for exocrine pancreatic function in infants and children. Arch Dis Child. 1978; 53(8):639-41. PMC: 1545053. DOI: 10.1136/adc.53.8.639. View

12.

Ashton M, Axon A, Lintott D . Lundh test and ERCP in pancreatic disease. Gut. 1978; 19(10):910-5. PMC: 1412364. DOI: 10.1136/gut.19.10.910. View

13.

Rolny P, Lukes P, GAMKLOU R, Jagenburg R, Nilson A . A comparative evaluation of endoscopic retrograde pancreatography and secretin-CCK test in the diagnosis of pancreatic disease. Scand J Gastroenterol. 1978; 13(7):777-81. DOI: 10.3109/00365527809182190. View

14.

Reuben A, Johnson A, Cotton P . Is pancreatogram interpretation reliable?--a study of observer variation and error. Br J Radiol. 1978; 51(612):956-62. DOI: 10.1259/0007-1285-51-612-956. View

15.

Mitchell C, Humphrey C, Bullen A, Kelleher J . The diagnostic value of the oral pancreatic function test. Scand J Gastroenterol. 1979; 14(2):183-7. DOI: 10.3109/00365527909179867. View

16.

Harada H, Mishima K, Shundo T, Yamamoto N, Sasaki T, Hinofuji T . Exocrine pancreatic function test by a synthetic peptide. Am J Gastroenterol. 1979; 71(1):45-52. View

17.

Mitchell C, Humphrey C, Bullen A, Kelleher J, Losowsky M . Improved diagnostic accuracy of a modified oral pancreatic function test. Scand J Gastroenterol. 1979; 14(6):737-41. DOI: 10.3109/00365527909181946. View

18.

Hoek F, Sanders G, Teunen A, Tijtgat G . In vitro and in vivo analysis of the PABA test compared with the Lundh test--influence of intraluminal pH. Gut. 1981; 22(1):8-13. PMC: 1419314. DOI: 10.1136/gut.22.1.8. View

19.

Mitchell C, Field H, Simpson F, Parkin A, Kelleher J, Losowsky M . Preliminary evaluation of a single-day tubeless test of pancreatic function. Br Med J (Clin Res Ed). 1981; 282(6278):1751-3. PMC: 1505724. DOI: 10.1136/bmj.282.6278.1751. View

20.

Braganza J, Hunt L, Warwick F . Relationship between pancreatic exocrine function and ductal morphology in chronic pancreatitis. Gastroenterology. 1982; 82(6):1341-7. View